Oil-Dri Announces Issuance of U.S. Patent for Mineral-Based Technology for Use in Antibiotic-Free Animal Protein Production
August 24 2020 - 10:00AM
Oil-Dri Corporation of America (NYSE: ODC), a leading manufacturer
of sorbent minerals, parent company to Amlan International, today
announced that the United States Patent and Trademark Office has
issued U.S. Patent 10,568,903 entitled “Clay Product and Uses
Thereof.” The patent covers two existing commercial products,
Varium® for poultry and NeoPrime™ for swine, that are helping
global animal protein producers thrive in an era of antibiotic-free
production.
This patent provides a methodology for using a natural,
mineral-based formula to mitigate the effects of exposure to
pathogenic bacteria and the disease-causing toxins they produce,
which damage gut health and function. Advancements in natural feed
additives are helping to transform animal protein production by
providing proven and reliable alternatives to in-feed antibiotics
used to promote growth and productivity.
“The United States is the second country to issue a patent for
this mineral-based technology and it validates the important role
that minerals play in disrupting the cycle of intestinal disease,”
said Daniel S. Jaffee, President and CEO of Oil-Dri Corporation of
America. “When using Varium, for example, poultry integrators have
eliminated the use of in-feed antibiotics to promote growth while
maintaining production efficiencies and profitability. Our
customers report they are growing healthier birds that are less
stressed and have increased the marketability of their products
through improved skin, liver and feet quality.”
“The market opportunity for natural alternatives to antibiotics
is large and growing,” says Flemming L. Mahs, President of Amlan
International, a Nevada corporation. “Market data indicates that
within medicinal feed additives, anti-infectives are a $2.4 billion
global market and usage has been declining as a result of changing
consumer sentiment towards the use of antibiotics and regulatory
restrictions limiting the use of antibiotics in animal protein
production. Intestinal disease costs the global livestock industry
more than $6 billion annually in economic loss and costs are rising
as sub-therapeutic antibiotic use declines.”
Mineral-Based Technology
Unlike antibiotics, which are designed to kill bacteria, the
patented technology includes a synergistic formula of three
ingredients with distinct modes of action: (1) a surface-activated
mineral that facilitates chemical binding of pathogenic intestinal
bacteria and the disease-causing toxins they produce; (2) an
immunomodulator that stimulates an animal’s innate immune system to
naturally defend against disease; and (3) an energy source for the
replenishment of intestinal epithelial cells that is essential for
healthy gut function. Upon inclusion of this patented technology in
animal feed, current producers have effectively eliminated the use
of antibiotics to promote growth and have experienced equivalent or
better outcomes.
Amlan International
Oil-Dri Corporation of America (NYSE: ODC), a Delaware
corporation doing business as “Amlan International,” is a global
leader in proven solutions that improve the intestinal health and
productivity of livestock. Amlan has grown its product offering
across the intestinal health and AGP-alternative market, driven
largely by the research conducted at its laboratory campus in
Vernon Hills, Illinois.
Amlan International sells animal health products outside of the
United States. Product associated claims do not constitute medical
claims and may differ based on government requirements. Product
availability may vary by country.
Reagan CulbertsonMedia Contactpress@amlan.com
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From Apr 2023 to Apr 2024